Genomic Valley Biotech has informed that a meeting of the Board of Directors of the Company is scheduled on held on May 30, 2016, to consider and approve the Audited Financial Results of the Company for the year ended on March 31, 2016. Further note that as per GVBL code of conduct for Prohibition of Insider Trading formulated, basis of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and as per the provisions of section 195 of the companies Act, 2013, The Trading window of the Company shall remain closed for trading in the Company equity shares from May 23, 2016 to June 03, 2016. Further to note that as per subject code for such of designated employees that can be reasonably expected to have possession of UPSI, the trading restriction applied to them from an earlier date and they had been intimated, not to trade in the equity shares of the Company till June 03, 2016.
The above information is a part of company’s filings submitted to BSE.
